Company / CapEx per Share
Fortress Biotech, Inc. CapEx per Share History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.00
FY2024
5-year range
$0.00 / $0.37
FY2020-FY2024
Trend
-98.9%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
CapEx per Share has fluctuated over the past 9 years, ranging from $0.00 in FY2016 to $0.37 in FY2023.
Based on SEC 10-K filings.
0.00 in FY2024 with a 5-year CAGR of -49.1%.
Declined from $0.05 to $0.00 over the past 2 years.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -41.0%
- 5-Year CAGR
- -49.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, capex per share decreased 98.9% year-over-year.
- Peak capex per share was recorded in FY2023.
- Lowest capex per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -1.10 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $0.00 | -98.9% |
| FY2023 | $0.37 | +718.8% |
| FY2022 | $0.05 | +121.7% |
| FY2021 | $0.02 | -35.9% |
| FY2020 | $0.03 | -74.1% |
| FY2019 | $0.12 | +863.4% |
| FY2018 | $0.01 | +119.7% |
| FY2017 | $0.01 | - |
| FY2016 | $0.00 | -100.0% |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026